EP1033910A4 - Dipeptide apoptosis inhibitors and the use thereof - Google Patents
Dipeptide apoptosis inhibitors and the use thereofInfo
- Publication number
- EP1033910A4 EP1033910A4 EP98952166A EP98952166A EP1033910A4 EP 1033910 A4 EP1033910 A4 EP 1033910A4 EP 98952166 A EP98952166 A EP 98952166A EP 98952166 A EP98952166 A EP 98952166A EP 1033910 A4 EP1033910 A4 EP 1033910A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- apoptosis inhibitors
- dipeptide
- dipeptide apoptosis
- inhibitors
- apoptosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940088872 Apoptosis inhibitor Drugs 0.000 title 1
- 108010016626 Dipeptides Proteins 0.000 title 1
- 239000000158 apoptosis inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6167697P | 1997-10-10 | 1997-10-10 | |
US61676 | 1997-10-10 | ||
PCT/US1998/021232 WO1999018781A1 (en) | 1997-10-10 | 1998-10-09 | Dipeptide apoptosis inhibitors and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1033910A1 EP1033910A1 (en) | 2000-09-13 |
EP1033910A4 true EP1033910A4 (en) | 2004-11-24 |
Family
ID=22037372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98952166A Withdrawn EP1033910A4 (en) | 1997-10-10 | 1998-10-09 | Dipeptide apoptosis inhibitors and the use thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1033910A4 (en) |
JP (1) | JP4439111B2 (en) |
KR (1) | KR100580333B1 (en) |
CN (1) | CN1138472C (en) |
AU (1) | AU741203B2 (en) |
BR (1) | BR9814817A (en) |
CA (1) | CA2306692C (en) |
EA (1) | EA200000409A1 (en) |
NO (1) | NO20001323L (en) |
WO (1) | WO1999018781A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184210B1 (en) | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
WO1999047154A1 (en) * | 1998-03-16 | 1999-09-23 | Cytovia, Inc. | Dipeptide caspase inhibitors and the use thereof |
WO1999062554A1 (en) * | 1998-05-29 | 1999-12-09 | Mochida Pharmaceutical Co., Ltd. | Preventives/remedies for autoimmune demyelinating diseases |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
RS51237B (en) | 1998-10-23 | 2010-12-31 | Kirin Amgen Inc. | Thrombopoietic compounds |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
CA2367340A1 (en) | 1999-03-16 | 2000-09-21 | Cytovia, Inc. | Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
WO2000061542A1 (en) | 1999-04-09 | 2000-10-19 | Cytovia, Inc. | Caspase inhibitors and the use thereof |
MXPA02002038A (en) | 1999-08-27 | 2002-10-31 | Cytovia Inc | SUBSTITUTED agr;HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF. |
US6566338B1 (en) * | 1999-10-12 | 2003-05-20 | Cytovia, Inc. | Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
US6303374B1 (en) | 2000-01-18 | 2001-10-16 | Isis Pharmaceuticals Inc. | Antisense modulation of caspase 3 expression |
DE10006889A1 (en) * | 2000-02-16 | 2001-09-06 | Procorde Gmbh | Use of inhibitors of caspase-3 or the caspase-activated deoxyribonuclease (CAD) for the treatment of heart diseases |
CN100358869C (en) * | 2000-03-29 | 2008-01-02 | 沃泰克斯药物股份有限公司 | Carbamate caspase inhibitors and uses thereof |
EP1923386A3 (en) | 2000-03-29 | 2008-05-28 | Vertex Pharmceuticals Incorporated | Carbamate caspase inhibitors and uses thereof |
AR028619A1 (en) * | 2000-05-23 | 2003-05-14 | Vertex Pharma | A CASPASAS INHIBITING COMPOUND |
US20020052323A1 (en) * | 2000-08-30 | 2002-05-02 | Jinhai Wang | Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents |
US6800619B2 (en) | 2000-09-13 | 2004-10-05 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
EP1317448B2 (en) | 2000-09-15 | 2011-05-04 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
DE60120219T2 (en) | 2000-12-21 | 2007-04-12 | Vertex Pharmaceuticals Inc., Cambridge | PYRAZOL COMPOUNDS AS PROTEIN KINASE INHIBITORS |
WO2002085899A1 (en) | 2001-04-19 | 2002-10-31 | Vertex Pharmaceuticals Incorporated | Heterocyclyldicarbamides as caspase inhibitors |
MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
PL374967A1 (en) | 2002-08-02 | 2005-11-14 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of gsk-3 |
EP1549224A1 (en) * | 2002-10-10 | 2005-07-06 | Becton Dickinson and Company | Sample collection system with caspase inhibitor |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
WO2007056221A2 (en) | 2005-11-03 | 2007-05-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
EP2152694A2 (en) | 2007-05-02 | 2010-02-17 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
JP5553751B2 (en) | 2007-07-31 | 2014-07-16 | バーテックス ファーマシューティカルズ インコーポレイテッド | Process for preparing 5-fluoro-1H-pyrazolo [3,4-b] pyridin-3-amine and its derivatives |
FR2923160B1 (en) * | 2007-11-02 | 2013-07-26 | Pasteur Institut | COMPOUNDS FOR PREVENTING OR TREATING VIRAL INFECTION. |
RU2011112802A (en) | 2008-09-03 | 2012-10-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | CO-CRYSTALS AND THEIR PHARMACEUTICAL COMPOSITIONS |
CN106317161B (en) * | 2015-06-29 | 2020-05-15 | 深圳翰宇药业股份有限公司 | Preparation method of fluoromethyl ketone peptide series compounds |
CN117045634A (en) * | 2022-05-06 | 2023-11-14 | 北京康蒂尼药业股份有限公司 | Dipeptide derivative composition and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015577A1 (en) * | 1990-04-04 | 1991-10-17 | Black, Roy, A. | INTERLEUKIN 1'beta' PROTEASE |
WO1996003982A1 (en) * | 1994-08-02 | 1996-02-15 | Sanofi Winthrop, Inc. | Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69226820T2 (en) * | 1991-06-21 | 1999-05-12 | Merck & Co., Inc., Rahway, N.J. | Peptidyl derivatives as inhibitors of interleukin-1B converting enzymes |
RU2206611C2 (en) * | 1991-08-30 | 2003-06-20 | Вертекс Фармасьютикалз Инкорпорейтед | DNA FRAGMENT, PLASMID VECTOR, METHOD FOR PREPARING POLYPEPTIDE AND POLYPEPTIDE ELICITING IL-1β PROTEASE ACTIVITY |
US5462939A (en) * | 1993-05-07 | 1995-10-31 | Sterling Winthrop Inc. | Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
JPH0789951A (en) * | 1993-06-03 | 1995-04-04 | Sterling Winthrop Inc | Interleukin-1 beta transfer enzyme inhibitor |
WO1998010778A1 (en) * | 1996-09-12 | 1998-03-19 | Idun Pharmaceuticals, Inc. | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
-
1998
- 1998-10-09 KR KR1020007003882A patent/KR100580333B1/en not_active IP Right Cessation
- 1998-10-09 BR BR9814817-6A patent/BR9814817A/en not_active IP Right Cessation
- 1998-10-09 EP EP98952166A patent/EP1033910A4/en not_active Withdrawn
- 1998-10-09 AU AU97930/98A patent/AU741203B2/en not_active Ceased
- 1998-10-09 EA EA200000409A patent/EA200000409A1/en unknown
- 1998-10-09 JP JP2000515426A patent/JP4439111B2/en not_active Expired - Fee Related
- 1998-10-09 WO PCT/US1998/021232 patent/WO1999018781A1/en active IP Right Grant
- 1998-10-09 CA CA2306692A patent/CA2306692C/en not_active Expired - Fee Related
- 1998-10-09 CN CNB988100223A patent/CN1138472C/en not_active Expired - Fee Related
-
2000
- 2000-03-14 NO NO20001323A patent/NO20001323L/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015577A1 (en) * | 1990-04-04 | 1991-10-17 | Black, Roy, A. | INTERLEUKIN 1'beta' PROTEASE |
WO1996003982A1 (en) * | 1994-08-02 | 1996-02-15 | Sanofi Winthrop, Inc. | Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
Non-Patent Citations (2)
Title |
---|
REVESZ L ET AL: "Synthesis of P1 aspartate-based peptide acyloxymethyl and fluoromethyl ketones as inhibitors of interleukin-1 beta-converting enzyme", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 35, no. 52, 1994, pages 9693 - 9696, XP002232097, ISSN: 0040-4039 * |
See also references of WO9918781A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1033910A1 (en) | 2000-09-13 |
AU741203B2 (en) | 2001-11-22 |
BR9814817A (en) | 2002-01-08 |
JP2001519358A (en) | 2001-10-23 |
CA2306692A1 (en) | 1999-04-22 |
CN1138472C (en) | 2004-02-18 |
KR100580333B1 (en) | 2006-05-16 |
JP4439111B2 (en) | 2010-03-24 |
NO20001323L (en) | 2000-06-13 |
EA200000409A1 (en) | 2000-10-30 |
CA2306692C (en) | 2010-09-21 |
AU9793098A (en) | 1999-05-03 |
KR20010031053A (en) | 2001-04-16 |
NO20001323D0 (en) | 2000-03-14 |
WO1999018781A1 (en) | 1999-04-22 |
CN1301131A (en) | 2001-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1033910A4 (en) | Dipeptide apoptosis inhibitors and the use thereof | |
EP1032377A4 (en) | Substituted 2-aminoacetamides and the use thereof | |
HUP0000427A3 (en) | Benzamidoaldehydes and their use as cysteine protease inhibitors | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
IL131661A0 (en) | Protease inhibitors | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
HUP0104500A3 (en) | Thrombin inhibitor dipeptide derivatives and their use | |
PL336589A1 (en) | Serinic protease inhibitors | |
PL328307A1 (en) | Serinic protease inhibitors | |
ZA983762B (en) | Protease inhibitors | |
ZA983841B (en) | Protease inhibitors | |
PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
PL328875A1 (en) | Serinic protease inhibitors | |
ZA983522B (en) | Protease inhibitors | |
PL328223A1 (en) | Aspartil protease inhibitors | |
GB9702354D0 (en) | Compounds and their use | |
EP1015438A4 (en) | Protease inhibitors | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
IL123535A0 (en) | Benzoxazindione derivatives and their use | |
EP0998578A4 (en) | Sel-10 AND USES THEREOF | |
EP0975612A4 (en) | Protease inhibitors | |
ZA984896B (en) | Carbohydrates and use thereof | |
PL341293A1 (en) | Beta-lypothropin and application thereof | |
GB9715323D0 (en) | Piperidinecarboxamides and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000428 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20000428;LT PAYMENT 20000428;LV PAYMENT 20000428;MK PAYMENT 20000428;RO PAYMENT 20000428;SI PAYMENT 20000428 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: DREWE, JOHN, A. Inventor name: YANG, WU Inventor name: GUASTELLA, JOHN Inventor name: CAI, SUI, XIONG Inventor name: KEANA, JOHN, F., W. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041013 |
|
17Q | First examination report despatched |
Effective date: 20091119 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20120322 |